Dr Paul Bradshaw obtained his PhD from the Institute of Cancer Research (ICR) at the Royal Cancer (Marsden) Hospital, University of London, UK. He then undertook his post-doctoral research studies in the Program of Genetics and Genome Biology at the Hospital for Sick Children. This was followed by a scientific associate position in the laboratory of Professor Michael Fehlings in the Department of Genetics and Development at the Krembil Research Institute (UHN). In 2018 he co-founded Inteligex and recently obtained his MBA from the Kellogg Schulich Global Executive MBA program.